Skip to main content
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. — Investor Relations & Filings

Ticker · DARE ISIN · US23666P1012 US Manufacturing
Filings indexed 726 across all filing types
Latest filing 2020-09-09 Regulatory Filings
Country US United States of America
Listing US DARE

About Dare Bioscience, Inc.

https://www.darebioscience.com/

Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative products for women's health. The company conducts end-to-end clinical development of therapies designed to address unmet needs in areas such as contraception, sexual health, vaginal health, and menopause. Its pipeline includes candidates like Ovaprene®, a hormone-free monthly contraceptive, and a topical sildenafil cream for female sexual arousal disorder. Dare Bioscience emphasizes a rigorous, science-based approach to develop medically credible and evidence-based solutions, aiming to close critical gaps in female healthcare.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2020-09-09 English
10-Q
Interim / Quarterly Report Q2 2020
2020-08-12 English
424B5
Prospectus
2020-07-15 English
FORM 4
Director's Dealing
2020-06-27 English
FORM 4
Director's Dealing
2020-06-27 English
FORM 4
Director's Dealing
2020-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.